Bernstein initiated coverage on Bristol-Myers with a new price target
$BMY
Biotechnology: Pharmaceutical Preparations
Health Care
Bernstein initiated coverage of Bristol-Myers with a rating of Mkt Perform and set a new price target of $56.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $55.00 | Neutral | Cantor Fitzgerald |
| 4/22/2025 | Overweight | Piper Sandler | |
| 12/16/2024 | $70.00 | Hold → Buy | Jefferies |
| 12/10/2024 | $63.00 | Neutral | BofA Securities |
| 11/15/2024 | Peer Perform | Wolfe Research | |
| 11/13/2024 | Neutral → Outperform | Daiwa Securities | |
| 11/12/2024 | $73.00 | Market Perform → Outperform | Leerink Partners |
| 10/25/2024 | $75.00 → $55.00 | Buy → Neutral | Citigroup |
11-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
11-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
11-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
3 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)
4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)
4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)